EuroStemCell Connect - stem cell projects in Europe

We work closely with other EU-funded stem cell projects, coordinating efforts to engage with the public about our science. Click the logos below to read more about the projects. You can see our extended network of research institutes and projects on our stem cell map of Europe.


	CardioCell aims to identify sources of cells that can be used to regenerate injured heart tissue. We are expanding our basic scientific knowledge about cardiomyocyte progenitors - a type of cell that produces heart muscle cells (cardiomyocytes). The new knowledge we generate will contribute to significant improvements in the prevention and treatment of cardiovascular diseases in Europe, and will help to maintain European competitiveness in this field of research.
	ESTOOLS, a Framework 6 Integrated Project, aimed to develop the tools and knowledge required for application of human embryonic stem (ES) cells in industry and medicine. It was the largest consortium of researchers studying human ES cells in Europe. The project teamed up 21 research groups, bringing together more than 150 scientists in 10 countries. It was the first EU-funded project focused entirely on human embryonic stem cells. ESTOOLS completed its 4 years of activity in July 2010.
	EuroSyStem - the European Federation for Systematic Stem Cell Biology - is an EU Framework 7 partnership. EuroSyStem aims to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells by interconnecting biological and computational expertise.
	The goal of the HEALING project is to uncover how stem cells influence the regeneration of cells and tissues. However, the aims of HEALING are about more than just understanding. We will develop new chemical substances to improve cell regeneration and wound-healing and ultimately to benefit patients with degenerative diseases or chronic wounds like ulcers.
	NeuroStemcell - the European Consortium for Stem Cell Therapy in Neurodegenerative Diseases - is an EU Framework 7 partnership. NeuroStemcell combines the expertise of 13 academic partners and three small-to-medium businesses from six countries. Its research focuses on stem-cell-based therapies for Parkinson’s and Huntington’s diseases.
	OptiStem brings stem cell biology and clinical science together in a drive to develop and test new stem-cell-based approaches to therapy. We are focussed on degenerative diseases of the skeletal muscle, and repair of diseased or damaged epithelial tissues such as the skin or cornea.
	REDDSTAR, Repair of Diabetic Damage by Stromal Cell Administration, is an EU funded project which will develop and test bone marrow derived stromal cell therapy to treat diabetes mellitus. The objective is to control blood glucose while also addressing a range of six diabetic complications.
	STELLAR is a research consortium consisting of European and Australian researchers interested in developing an alternative to renal replacement therapy. The STELLAR consortium will make use of newly discovered kidney mesenchymal stromal cells that have the potential to regenerate and repair damaged tissue.

EuroStemCell Connect - stem cell projects in Europe

Languages